Author's reply: Phase I/II study of adding intraperitoneal paclitaxel in patients with pancreatic cancer and peritoneal metastasis (Br J Surg 2020; 107: 1811-1817). - Yamada S; Fujii T; Satoi S (The British journal of surgery, 2021)